Ratings
0
Nobody has rated this yet. Be the first!
Works
6
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
Telomere length is greater in ALS than in controls: a whole genome sequencing study
Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).
Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis
Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
